Shift Bioscience
United Kingdom · $16.0M raised
- Employees
- 1–10
- Business Model
- B2B
- Website
- shiftbioscience.com
- Total Funding
- $16.0M
- Last Round
- $16.0M SeedOct 2024
- Rounds
- 1
About
Biotech company using cell biology and machine learning to reverse aging through cell rejuvenation therapies.
Summary
Shift Bioscience is a Biotech company based in United Kingdom. It has raised $16.0M in total across 1 round, most recently a $16.0M Seed round in Oct 2024. Investors include BGF, F-Prime Capital and Kindred Capital.
Tech & App Stack
4 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Oct 2024
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...